Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 18/20 | 0.46 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.43 |
| ▸ | RORA | P35398 | 2/20 | 0.40 |
| ▸ | RORB | Q92753 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4154565 | 0.96 | RORC (0.41) | RORCTLR7RORARORB | |
| SCHEMBL4154435 | 0.92 | RORC (0.36) | RORCTLR7RORARORB | |
| SCHEMBL4149997 | 0.90 | RORC (0.41) | RORCTLR7RORARORB | |
| SCHEMBL4149344 | 0.90 | RORC (0.43) | RORCTLR7RORARORB | |
| SCHEMBL4141906 | 0.90 | RORC (0.43) | RORCTLR7RORARORB | |
| SCHEMBL4157914 | 0.88 | RORC (0.48) | RORCTLR7RORARORB | |
| SCHEMBL4151347 | 0.85 | RORC (0.46) | RORCTLR7RORARORB | |
| SCHEMBL4155292 | 0.84 | RORC (0.38) | RORCTLR7RORARORB | |
| SCHEMBL4158854 | 0.84 | RORC (0.35) | RORCTLR7RORARORB | |
| SCHEMBL4636222 | 0.83 | CES2 (0.35) | RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090176786-A1 | Benzoylurea Compounds and Use Thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-09 | — | — | US | disclosed |
| US-20090176786-A1 | Benzoylurea Compounds and Use Thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-09 | — | — | US | disclosed |
| US-20090176786-A1 | Benzoylurea Compounds and Use Thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-09 | — | — | US | disclosed |
| EP-1937629-A2 | BENZOYLUREA COMPOUNDS AND USE THEREOF | Sumitomo Chemical Company, Limited (JP) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007046513-A2 | BENZOYLUREA COMPOUNDS AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176786-A1 | Benzoylurea Compounds and Use Thereof | BTK, BRIX1, NFXL1 | RORC 4448/4885TLR7 905/4885RORA 4206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.